Mirum Pharmaceuticals, Inc. (MIRM)
USD 41.5
(-4.0%)
USD 41.5
(-4.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 397.95 Million USD | 88.72% |
| 2022 | 210.86 Million USD | 20.88% |
| 2021 | 174.43 Million USD | 153.66% |
| 2020 | 68.76 Million USD | 320.27% |
| 2019 | 16.36 Million USD | -73.73% |
| 2018 | 62.29 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 431.76 Million USD | 3.45% |
| 2024 Q1 | 417.35 Million USD | 4.88% |
| 2023 Q4 | 397.95 Million USD | 4.3% |
| 2023 Q3 | 381.56 Million USD | 4.54% |
| 2023 FY | 397.95 Million USD | 88.72% |
| 2023 Q1 | 192.38 Million USD | -8.77% |
| 2023 Q2 | 364.97 Million USD | 89.72% |
| 2022 Q2 | 186.54 Million USD | 10.24% |
| 2022 Q1 | 169.21 Million USD | -2.99% |
| 2022 FY | 210.86 Million USD | 20.88% |
| 2022 Q4 | 210.86 Million USD | 8.11% |
| 2022 Q3 | 195.05 Million USD | 4.56% |
| 2021 Q1 | 88.35 Million USD | 28.49% |
| 2021 FY | 174.43 Million USD | 153.66% |
| 2021 Q4 | 174.43 Million USD | -2.42% |
| 2021 Q3 | 178.77 Million USD | 17.67% |
| 2021 Q2 | 151.93 Million USD | 71.95% |
| 2020 Q1 | 16.68 Million USD | 1.97% |
| 2020 Q4 | 68.76 Million USD | 218.23% |
| 2020 FY | 68.76 Million USD | 320.27% |
| 2020 Q3 | 21.61 Million USD | 10.49% |
| 2020 Q2 | 19.55 Million USD | 17.22% |
| 2019 Q3 | 12.07 Million USD | -90.87% |
| 2019 Q1 | 67.56 Million USD | 2658.76% |
| 2019 FY | 16.36 Million USD | -73.73% |
| 2019 Q4 | 16.36 Million USD | 35.57% |
| 2019 Q2 | 132.21 Million USD | 95.7% |
| 2018 FY | 62.29 Million USD | 0.0% |
| 2018 Q4 | 2.44 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -18.517% |
| Alkermes plc | 933.53 Million USD | 57.372% |
| Agenus Inc. | 462.29 Million USD | 13.918% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 90.175% |
| Aptorum Group Limited | 5.25 Million USD | -7470.303% |
| Ardelyx, Inc. | 130.76 Million USD | -204.33% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 16.815% |
| Bicycle Therapeutics plc | 224.41 Million USD | -77.331% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -205.622% |
| ChromaDex Corporation | 26.5 Million USD | -1401.249% |
| Chimerix, Inc. | 19.74 Million USD | -1915.452% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1031.278% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -448.391% |
| CRISPR Therapeutics AG | 346.76 Million USD | -14.76% |
| Precision BioSciences, Inc. | 140.92 Million USD | -182.395% |
| Dyadic International, Inc. | 2.34 Million USD | -16901.723% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2346.972% |
| Fortress Biotech, Inc. | 165.93 Million USD | -139.818% |
| Lantern Pharma Inc. | 2.73 Million USD | -14425.445% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -456.731% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -11177.473% |
| Incyte Corporation | 1.59 Billion USD | 75.007% |
| IO Biotech, Inc. | 17.55 Million USD | -2166.752% |
| Jaguar Health, Inc. | 45.86 Million USD | -767.638% |
| Novavax, Inc. | 2.57 Billion USD | 84.529% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1003.641% |
| Opthea Limited | 264.6 Million USD | -50.396% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -204.46% |
| ContextLogic Inc. | 206 Million USD | -93.18% |
| MiMedx Group, Inc. | 96.33 Million USD | -313.112% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -728.685% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -11176.955% |
| NextCure, Inc. | 14.99 Million USD | -2553.537% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -9745.398% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5860.027% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -751.432% |
| Vaxcyte, Inc. | 167.44 Million USD | -137.655% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1096.516% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -69.187% |
| Pharming Group N.V. | 244.07 Million USD | -63.046% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3237.955% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -211.408% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5922.918% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5922.918% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -382.757% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5890.531% |
| Acelyrin, Inc. | 86.35 Million USD | -360.842% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -30529.498% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2667.585% |
| Summit Therapeutics Inc. | 125.25 Million USD | -217.708% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -4098.238% |
| Senti Biosciences, Inc. | 52.57 Million USD | -656.978% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -478.611% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -162.653% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -20245.143% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -29696.475% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -75.439% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -4148.436% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -74.966% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 19.526% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3546.243% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1346.516% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3187.575% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 18.218% |
| Immix Biopharma, Inc. | 3.72 Million USD | -10592.483% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -952.446% |
| MEI Pharma, Inc. | 8.35 Million USD | -4663.028% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1271.535% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -14.492% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -172.814% |
| Fortress Biotech, Inc. | 165.93 Million USD | -139.818% |
| Precigen, Inc. | 41.64 Million USD | -855.602% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -697.018% |
| AlloVir, Inc. | 45.01 Million USD | -784.041% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -205.325% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -188.789% |
| ImmuCell Corporation | 18.81 Million USD | -2015.07% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1309.874% |
| Onconetix, Inc. | 23.18 Million USD | -1616.72% |
| PureTech Health plc | 125.58 Million USD | -216.883% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4346.38% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1060.816% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -16176.115% |
| Seer, Inc. | 39.36 Million USD | -910.926% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -543.58% |
| Innoviva, Inc. | 568.55 Million USD | 30.006% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1361.551% |
| ESSA Pharma Inc. | 3.49 Million USD | -11286.063% |
| GlycoMimetics, Inc. | 6.9 Million USD | -5665.673% |
| GT Biopharma, Inc. | 6.63 Million USD | -5899.563% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -50.517% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -46.151% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -373.605% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3971.526% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1364.725% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -12236.609% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -439.47% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2417.291% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3504.731% |
| Soligenix, Inc. | 7.27 Million USD | -5370.189% |
| Century Therapeutics, Inc. | 175.94 Million USD | -126.184% |
| Kura Oncology, Inc. | 51.66 Million USD | -670.297% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -228.12% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -9528.623% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5916.93% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -57.543% |
| Autolus Therapeutics plc | 263.9 Million USD | -50.792% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3696.518% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -347.835% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -748.528% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -12.78% |
| GRI Bio, Inc. | 2.69 Million USD | -14655.321% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -49054.937% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1179.956% |
| IGM Biosciences, Inc. | 220.17 Million USD | -80.741% |
| INmune Bio, Inc. | 18.86 Million USD | -2009.803% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -55.159% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1393.708% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14539.13% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -12031.669% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -580.782% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -313.847% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -50.321% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 51.648% |
| Verastem, Inc. | 71.18 Million USD | -459.038% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -709.238% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -931.549% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -713.274% |
| Histogen Inc. | 5.69 Million USD | -6885.273% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -8974.027% |
| Surrozen, Inc. | 8.14 Million USD | -4785.832% |
| Organovo Holdings, Inc. | 2.74 Million USD | -14381.477% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -126693.327% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -607.721% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2310.071% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -678.723% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -48027.105% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -214.027% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3580.101% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -163.738% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -15162.691% |
| Apollomics, Inc. | 14.15 Million USD | -2711.778% |
| Amarin Corporation plc | 279.58 Million USD | -42.335% |
| Mesoblast Limited | 188.79 Million USD | -110.781% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2712.772% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -120.12% |
| Synaptogenix, Inc. | 5.52 Million USD | -7096.912% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5886.026% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -133.94% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4550.485% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -22544.394% |
| Exelixis, Inc. | 678.44 Million USD | 41.344% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1569.118% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -142.585% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 33.028% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3626.062% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -24410.167% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -922.301% |
| Gritstone bio, Inc. | 125.91 Million USD | -216.037% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2611.577% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -7720.4% |
| Avid Bioservices, Inc. | 275.66 Million USD | -44.359% |
| Insmed Incorporated | 1.66 Billion USD | 76.052% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -5072.209% |
| MediWound Ltd. | 27.18 Million USD | -1363.755% |
| OmniAb, Inc. | 87.4 Million USD | -355.322% |
| Alector, Inc. | 487.66 Million USD | 18.397% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 1.364% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2059.843% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -937.06% |
| Zai Lab Limited | 240.17 Million USD | -65.691% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 36.839% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1261.587% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -318.557% |
| Immunic, Inc. | 25.36 Million USD | -1468.713% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -474.775% |
| Veracyte, Inc. | 93.71 Million USD | -324.621% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -15108.282% |
| FibroGen, Inc. | 585.72 Million USD | 32.059% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2189.311% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -60834.868% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -6936.583% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 94.802% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4754.245% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -373.627% |
| TG Therapeutics, Inc. | 169.08 Million USD | -135.356% |
| Galecto, Inc. | 5.89 Million USD | -6649.508% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4703.851% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 84.802% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1280.72% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3053.086% |
| XBiotech Inc. | 8.39 Million USD | -4639.204% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2611.577% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -648.31% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -9.596% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1380.252% |
| Theravance Biopharma, Inc. | 169 Million USD | -135.468% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 67.263% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 20.478% |
| Vaxxinity, Inc. | 30.94 Million USD | -1186.036% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 59.079% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -6498.308% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 46.601% |
| NexImmune, Inc. | 5.08 Million USD | -7727.161% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -107050.627% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -12842.136% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 94.401% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -7621.162% |
| Scopus BioPharma Inc. | 7.45 Million USD | -5238.447% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1413.467% |
| Ainos, Inc. | 7.39 Million USD | -5281.918% |
| Pluri Inc. | 34.11 Million USD | -1066.601% |
| Prothena Corporation plc | 135.01 Million USD | -194.741% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -63.696% |
| Celularity Inc. | 102.92 Million USD | -286.627% |
| Rallybio Corporation | 9.43 Million USD | -4117.37% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1527.944% |
| MeiraGTx Holdings plc | 319.99 Million USD | -24.363% |
| Omeros Corporation | 403.25 Million USD | 1.315% |
| Humacyte, Inc. | 114.67 Million USD | -247.019% |
| Immunocore Holdings plc | 228.15 Million USD | -74.419% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -8063.097% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -418.57% |
| Blueprint Medicines Corporation | 918.64 Million USD | 56.68% |
| CalciMedica, Inc. | 4.02 Million USD | -9779.618% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2180.26% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -158.17% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -363.72% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -43.255% |
| Pulmatrix, Inc. | 15.96 Million USD | -2392.959% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2422.989% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1517.293% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -58.668% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -683.584% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 67.129% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1152.088% |
| Nutriband Inc. | 1.07 Million USD | -36784.233% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3642.603% |
| Vor Biopharma Inc. | 59.1 Million USD | -573.306% |
| Roivant Sciences Ltd. | 773.95 Million USD | 48.582% |
| Evogene Ltd. | 17.99 Million USD | -2112.068% |
| ProKidney Corp. | 29.21 Million USD | -1262.1% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -452.871% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -56348.312% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 78.932% |
| CorMedix Inc. | 11.91 Million USD | -3239.208% |
| BioLineRx Ltd. | 50.7 Million USD | -684.882% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -166.261% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -349.962% |
| Atai Life Sciences N.V. | 49.16 Million USD | -709.469% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1177.437% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2115.516% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -219.291% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -6938.398% |
| MediciNova, Inc. | 3.89 Million USD | -10126.02% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2077.094% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26355.269% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11205.808% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -0.174% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1196.68% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 85.379% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2393.115% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1175.443% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -578.125% |
| Absci Corporation | 58.3 Million USD | -582.545% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1989.201% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1141.192% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -439.302% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -354.89% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1078.416% |
| Allakos Inc. | 74.79 Million USD | -432.07% |
| Imunon, Inc. | 8.53 Million USD | -4565.077% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1668.593% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -246.611% |
| BioAtla, Inc. | 48.98 Million USD | -712.377% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3626.062% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -14219.935% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -204.7% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2699.515% |
| XOMA Corporation | 145.58 Million USD | -173.356% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1082.091% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -478.762% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1159.458% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -543.694% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -785.024% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -722.179% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -13765.889% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4778.035% |
| Akari Therapeutics, Plc | 4.58 Million USD | -8581.305% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2144.11% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 75.874% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -98425.159% |
| UroGen Pharma Ltd. | 243.52 Million USD | -63.414% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -23.939% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -14310.38% |
| Orgenesis Inc. | 35.53 Million USD | -1019.885% |
| Entera Bio Ltd. | 1.37 Million USD | -28757.941% |
| GH Research PLC | 6.7 Million USD | -5838.681% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -5752.221% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2013.837% |
| Xencor, Inc. | 283.55 Million USD | -40.342% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -13228.678% |
| Replimune Group, Inc. | 113.21 Million USD | -251.503% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -10491.902% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -284.382% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -98425.159% |
| Portage Biotech Inc. | 4.45 Million USD | -8842.719% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26355.269% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1626.469% |
| OncoCyte Corporation | 49.29 Million USD | -707.236% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -9519.767% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -49800.813% |
| Purple Biotech Ltd. | 10 Million USD | -3877.521% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -6777.826% |
| scPharmaceuticals Inc. | 57.26 Million USD | -594.977% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3112.386% |
| HilleVax, Inc. | 78.9 Million USD | -404.316% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -7780.218% |
| Tharimmune, Inc. | 1.81 Million USD | -21825.119% |
| Genprex, Inc. | 3.25 Million USD | -12128.813% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1367.425% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -7500.286% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -193080.097% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -110889.603% |
| OKYO Pharma Limited | 7.42 Million USD | -5262.61% |
| Savara Inc. | 37.19 Million USD | -969.991% |
| Curis, Inc. | 57.61 Million USD | -590.743% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1411.406% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -915.186% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -27458.934% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1811.48% |
| BeiGene, Ltd. | 2.23 Billion USD | 82.185% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1769.21% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -51.66% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1770.598% |
| Erasca, Inc. | 78.61 Million USD | -406.228% |
| bluebird bio, Inc. | 424.62 Million USD | 6.282% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -60632.512% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 78.945% |
| DBV Technologies S.A. | 42.8 Million USD | -829.792% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -60632.512% |
| Moderna, Inc. | 4.57 Billion USD | 91.296% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -5589.078% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -23930.857% |
| Molecular Templates, Inc. | 31.17 Million USD | -1176.671% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2231.289% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 32.333% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -219.627% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1350.417% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -991.593% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -615.289% |
| MacroGenics, Inc. | 154.2 Million USD | -158.063% |
| RenovoRx, Inc. | 4.46 Million USD | -8810.681% |
| Adicet Bio, Inc. | 37.12 Million USD | -972.066% |
| Prime Medicine, Inc. | 60.78 Million USD | -554.74% |
| Aditxt, Inc. | 28.53 Million USD | -1294.775% |
| Adagene Inc. | 45.16 Million USD | -781.02% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -220126.23% |
| Quantum-Si incorporated | 26.63 Million USD | -1394.315% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 42.951% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -12980.004% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -246.162% |
| SciSparc Ltd. | 1.59 Million USD | -24849.906% |
| Vericel Corporation | 127.7 Million USD | -211.617% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7051.098% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -366.214% |
| Generation Bio Co. | 171.63 Million USD | -131.866% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3345.463% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -851.33% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -57.481% |
| Invivyd, Inc. | 51.71 Million USD | -669.538% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -332.664% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -6017.381% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -427.115% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -38876.592% |
| 2seventy bio, Inc. | 310.12 Million USD | -28.319% |
| ADMA Biologics, Inc. | 193.97 Million USD | -105.155% |
| Clene Inc. | 38.95 Million USD | -921.671% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1001.355% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -54.859% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11205.808% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -109.158% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3167.34% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -100.659% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3163.284% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -727.152% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -653.11% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -7.597% |
| Evaxion Biotech A/S | 17.61 Million USD | -2158.842% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -147.284% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -159.783% |
| Trevena, Inc. | 48.26 Million USD | -724.564% |
| Surrozen, Inc. | 8.14 Million USD | -4785.832% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1742.792% |
| Cingulate Inc. | 10.36 Million USD | -3740.905% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -14370.945% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -967.122% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -10995.742% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2926.243% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -25.457% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1501.477% |
| Clearmind Medicine Inc. | 3.61 Million USD | -10923.549% |
| Kronos Bio, Inc. | 54.2 Million USD | -634.213% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -745.93% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1648.487% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1882.716% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1654.908% |
| ImmunityBio, Inc. | 1.09 Billion USD | 63.504% |
| Korro Bio, Inc. | 51.75 Million USD | -668.958% |
| Kineta, Inc. | 7.22 Million USD | -5410.26% |
| BioVie Inc. | 9.7 Million USD | -4001.687% |
| Codexis, Inc. | 49.94 Million USD | -696.763% |
| Celularity Inc. | 102.92 Million USD | -286.627% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -313.468% |
| Celcuity Inc. | 51.45 Million USD | -673.47% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -115183.29% |
| Cibus, Inc. | 206.11 Million USD | -93.07% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -836.906% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1410.881% |
| IN8bio, Inc. | 8.77 Million USD | -4436.605% |
| Kodiak Sciences Inc. | 213.59 Million USD | -86.314% |
| Annexon, Inc. | 47.11 Million USD | -744.584% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -344.434% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -312.932% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2807.086% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 84.714% |
| Eyenovia, Inc. | 19.78 Million USD | -1911.857% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -124.722% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5080.979% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1551.317% |
| Arcellx, Inc. | 339.75 Million USD | -17.13% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3244.688% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -62.072% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4061.361% |
| Moolec Science SA | 13.94 Million USD | -2753.645% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -822.208% |
| Geron Corporation | 146.12 Million USD | -172.332% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -687.523% |
| Royalty Pharma plc | 6.29 Billion USD | 93.681% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -900.48% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -135070.819% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -16075.016% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -110.382% |
| Humacyte, Inc. | 114.67 Million USD | -247.019% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1269.836% |
| 89bio, Inc. | 59.96 Million USD | -563.661% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1403.802% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -33173.495% |
| Genelux Corporation | 8.42 Million USD | -4626.259% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -5704.419% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -191.926% |
| Notable Labs, Ltd. | 4.42 Million USD | -8889.18% |
| Liquidia Corporation | 73.13 Million USD | -444.11% |
| Mustang Bio, Inc. | 17.61 Million USD | -2158.647% |
| Immunovant, Inc. | 48.95 Million USD | -712.891% |
| Quantum-Si incorporated | 26.63 Million USD | -1394.315% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -936.79% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -12724.718% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -438.784% |
| Acasti Pharma Inc. | 11.55 Million USD | -3343.376% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1660.243% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14539.13% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -979.131% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -29100.083% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -6428.068% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1502.38% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1616.49% |
| PepGen Inc. | 34.63 Million USD | -1049.118% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3176.935% |
| United Therapeutics Corporation | 1.18 Billion USD | 66.338% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -5598.038% |
| Solid Biosciences Inc. | 38.45 Million USD | -934.768% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4550.485% |
| Immuneering Corporation | 12 Million USD | -3213.951% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -126693.327% |
| Silo Pharma, Inc. | 1.56 Million USD | -25258.989% |
| Belite Bio, Inc | 4.21 Million USD | -9350.273% |
| XOMA Corporation | 145.58 Million USD | -173.356% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -16290.074% |
| Bionomics Limited | 10.15 Million USD | -3817.334% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1751.71% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1636.791% |
| uniQure N.V. | 624.01 Million USD | 36.228% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2703.459% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -220126.23% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -133.836% |
| Forte Biosciences, Inc. | 3.66 Million USD | -10755.183% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -152615.641% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5798.192% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5080.979% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2189.311% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3665.623% |
| Altimmune, Inc. | 16.54 Million USD | -2305.846% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 35.576% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1636.791% |
| Compugen Ltd. | 55.77 Million USD | -613.494% |
| Peak Bio, Inc. | 20.75 Million USD | -1817.525% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -260.257% |
| Benitec Biopharma Inc. | 4.96 Million USD | -7919.972% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -152.118% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -429.373% |
| Zura Bio Limited | 21.29 Million USD | -1769.017% |
| PolyPid Ltd. | 17.46 Million USD | -2178.172% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -254.052% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -429.373% |
| Instil Bio, Inc. | 99.8 Million USD | -298.745% |
| argenx SE | 444.95 Million USD | 10.563% |
| Immunome, Inc. | 28.65 Million USD | -1288.621% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4673.312% |
| Verona Pharma plc | 58.84 Million USD | -576.316% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2649.61% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2578.182% |
| CervoMed Inc. | 2.59 Million USD | -15230.885% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -8064.772% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3024.615% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3677.418% |
| Moolec Science SA | 13.94 Million USD | -2753.645% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -16881.025% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -615.8% |
| AnaptysBio, Inc. | 364.28 Million USD | -9.241% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3228.463% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3037.425% |
| NeurAxis, Inc. | 1.91 Million USD | -20705.295% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -922.274% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2884.707% |
| Achilles Therapeutics plc | 19.08 Million USD | -1984.932% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2649.61% |
| 180 Life Sciences Corp. | 5.38 Million USD | -7286.96% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1587.092% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1648.487% |
| Nutriband Inc. | 1.07 Million USD | -36784.233% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1200.578% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2642.409% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 0.828% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1125.483% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2949.644% |
| Palisade Bio, Inc. | 2.73 Million USD | -14429.062% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -7475.69% |
| Beam Therapeutics Inc. | 478.38 Million USD | 16.814% |
| Neurogene Inc. | 36.54 Million USD | -988.815% |
| AEON Biopharma, Inc. | 159.88 Million USD | -148.892% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -735.154% |
| Sesen Bio, Inc. | 30.98 Million USD | -1184.376% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1432.88% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -5134.671% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -103.308% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -107.205% |
| Athira Pharma, Inc. | 30.05 Million USD | -1223.988% |
| Vaccinex, Inc. | 5.94 Million USD | -6597.257% |
| HCW Biologics Inc. | 15.05 Million USD | -2543.851% |
| XOMA Corporation | 145.58 Million USD | -173.356% |
| Nektar Therapeutics | 267.04 Million USD | -49.02% |
| Arvinas, Inc. | 644.6 Million USD | 38.264% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2144.11% |
| Merus N.V. | 102.15 Million USD | -289.571% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -171.917% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -318.367% |
| Rezolute, Inc. | 11.73 Million USD | -3291.435% |
| Clene Inc. | 38.95 Million USD | -921.671% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -13876.041% |
| BeyondSpring Inc. | 48.26 Million USD | -724.444% |
| Synlogic, Inc. | 32.89 Million USD | -1109.761% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2623.267% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -24254.406% |
| Peak Bio, Inc. | 20.75 Million USD | -1817.525% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -527.099% |
| Krystal Biotech, Inc. | 39.71 Million USD | -902.042% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -5.657% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -299.674% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -91863.737% |
| MannKind Corporation | 721.36 Million USD | 44.834% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1681.737% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -18977.229% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -287.904% |
| Gossamer Bio, Inc. | 249.14 Million USD | -59.725% |
| CohBar, Inc. | 1.03 Million USD | -38400.036% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3622.996% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1989.201% |
| Legend Biotech Corporation | 589.93 Million USD | 32.543% |
| Mural Oncology plc | 37.92 Million USD | -949.227% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -200.032% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -17237.405% |
| Disc Medicine, Inc. | 22.87 Million USD | -1639.677% |
| Champions Oncology, Inc. | 28.03 Million USD | -1319.479% |
| REGENXBIO Inc. | 262.22 Million USD | -51.758% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -11746.064% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3074.972% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2862.791% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1776.685% |
| Vaxart, Inc. | 34.02 Million USD | -1069.584% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1851.767% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1294.759% |
| Cellectis S.A. | 249.57 Million USD | -59.451% |
| Longeveron Inc. | 5.33 Million USD | -7356.455% |
| Repare Therapeutics Inc. | 41.81 Million USD | -851.603% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 83.455% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -559.209% |
| Revolution Medicines, Inc. | 262.39 Million USD | -51.66% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -18787.091% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -4513.39% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3272.18% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2733.803% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -18400.744% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 92.272% |
| Denali Therapeutics Inc. | 122.96 Million USD | -223.635% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7051.098% |
| Veru Inc. | 32.81 Million USD | -1112.795% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -5693.434% |
| Cingulate Inc. | 10.36 Million USD | -3740.905% |
| Passage Bio, Inc. | 39.26 Million USD | -913.578% |
| Context Therapeutics Inc. | 4.19 Million USD | -9393.751% |
| Exicure, Inc. | 8.54 Million USD | -4554.942% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1248.621% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3695.07% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1705.503% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -144.163% |
| Nuvalent, Inc. | 31.82 Million USD | -1150.514% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -6155.491% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -531.448% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2110.839% |
| OmniAb, Inc. | 87.4 Million USD | -355.322% |
| Anew Medical, Inc. | 8.24 Million USD | -4728.448% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -939.333% |
| Lipocine Inc. | 2.63 Million USD | -15021.85% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1414.734% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -889.632% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1393.708% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -361.907% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -7268.099% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -380.925% |
| Ocugen, Inc. | 23.98 Million USD | -1559.305% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -757.524% |
| Q32 Bio Inc. | 233.12 Million USD | -70.701% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4289.488% |
| Alumis Inc. Common Stock | 53.5 Million USD | -643.806% |
| Equillium, Inc. | 27.95 Million USD | -1323.44% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -92.627% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -6972.591% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -6388.718% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -152.947% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -473.144% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3889.803% |
| Dominari Holdings Inc. | 4.63 Million USD | -8485.782% |
| Edesa Biotech, Inc. | 1.84 Million USD | -21508.547% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1245.93% |
| Bio-Techne Corporation | 744.34 Million USD | 46.536% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -215.586% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -15.53% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -880.779% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1274.283% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -330.869% |
| Nkarta, Inc. | 105.6 Million USD | -276.848% |
| BioCardia, Inc. | 4.59 Million USD | -8569.956% |
| Iterum Therapeutics plc | 32.66 Million USD | -1118.391% |